Page last updated: 2024-08-17

dextroamphetamine and quetiapine fumarate

dextroamphetamine has been researched along with quetiapine fumarate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Garcia, C; Grafman, J; Huey, ED; Tierney, MC; Wassermann, EM	1
Potvin, S; Rompré, PP; Stip, E; Zhornitsky, S	1
Baker, K; Ibrahim, BA; Kelly, MP; McCarthy, SA; Pathak, G	1

Trials

1 trial(s) available for dextroamphetamine and quetiapine fumarate

Article	Year
Stimulant treatment of frontotemporal dementia in 8 patients. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:12 Topics: Antipsychotic Agents; Central Nervous System Stimulants; Cross-Over Studies; Dementia; Dextroamphetamine; Dibenzothiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Neuropsychological Tests; Quetiapine Fumarate	2008

Other Studies

2 other study(ies) available for dextroamphetamine and quetiapine fumarate

Article	Year
Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:10 Topics: Amphetamine-Related Disorders; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Dextroamphetamine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Tolerance; Electric Stimulation; Hypothalamus; Male; Pleasure; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Reward; Schizophrenia; Substance Withdrawal Syndrome	2010
Amphetamine sensitization in mice is sufficient to produce both manic- and depressive-related behaviors as well as changes in the functional connectivity of corticolimbic structures. Neuropharmacology, 2015, Volume: 95 Topics: Anhedonia; Animals; Bipolar Disorder; Cerebral Cortex; Dextroamphetamine; Disease Models, Animal; Limbic System; Lithium Compounds; Male; Memory Consolidation; Mice; Mice, Inbred C57BL; Motor Activity; Nesting Behavior; Neural Pathways; Psychotropic Drugs; Quetiapine Fumarate; Restraint, Physical; Species Specificity; Stress, Psychological; Substance Withdrawal Syndrome	2015

Article

Year

Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:10

Topics: Amphetamine-Related Disorders; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Dextroamphetamine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Tolerance; Electric Stimulation; Hypothalamus; Male; Pleasure; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Reward; Schizophrenia; Substance Withdrawal Syndrome

2010

Amphetamine sensitization in mice is sufficient to produce both manic- and depressive-related behaviors as well as changes in the functional connectivity of corticolimbic structures.

Neuropharmacology, 2015, Volume: 95

Topics: Anhedonia; Animals; Bipolar Disorder; Cerebral Cortex; Dextroamphetamine; Disease Models, Animal; Limbic System; Lithium Compounds; Male; Memory Consolidation; Mice; Mice, Inbred C57BL; Motor Activity; Nesting Behavior; Neural Pathways; Psychotropic Drugs; Quetiapine Fumarate; Restraint, Physical; Species Specificity; Stress, Psychological; Substance Withdrawal Syndrome

2015